1. Home
  2. EVGN vs SNGX Comparison

EVGN vs SNGX Comparison

Compare EVGN & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVGN
  • SNGX
  • Stock Information
  • Founded
  • EVGN 1999
  • SNGX 1987
  • Country
  • EVGN Israel
  • SNGX United States
  • Employees
  • EVGN N/A
  • SNGX N/A
  • Industry
  • EVGN Agricultural Chemicals
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVGN Industrials
  • SNGX Health Care
  • Exchange
  • EVGN Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • EVGN 11.6M
  • SNGX 10.1M
  • IPO Year
  • EVGN N/A
  • SNGX 1987
  • Fundamental
  • Price
  • EVGN $1.21
  • SNGX $2.81
  • Analyst Decision
  • EVGN Strong Buy
  • SNGX Strong Buy
  • Analyst Count
  • EVGN 1
  • SNGX 1
  • Target Price
  • EVGN $3.50
  • SNGX $6.00
  • AVG Volume (30 Days)
  • EVGN 41.5K
  • SNGX 659.7K
  • Earning Date
  • EVGN 08-19-2025
  • SNGX 11-07-2025
  • Dividend Yield
  • EVGN N/A
  • SNGX N/A
  • EPS Growth
  • EVGN N/A
  • SNGX N/A
  • EPS
  • EVGN N/A
  • SNGX N/A
  • Revenue
  • EVGN $9,444,000.00
  • SNGX N/A
  • Revenue This Year
  • EVGN N/A
  • SNGX N/A
  • Revenue Next Year
  • EVGN $63.64
  • SNGX N/A
  • P/E Ratio
  • EVGN N/A
  • SNGX N/A
  • Revenue Growth
  • EVGN N/A
  • SNGX N/A
  • 52 Week Low
  • EVGN $0.95
  • SNGX $1.09
  • 52 Week High
  • EVGN $3.32
  • SNGX $6.23
  • Technical
  • Relative Strength Index (RSI)
  • EVGN 44.36
  • SNGX 49.49
  • Support Level
  • EVGN $1.16
  • SNGX $2.58
  • Resistance Level
  • EVGN $1.29
  • SNGX $2.98
  • Average True Range (ATR)
  • EVGN 0.06
  • SNGX 0.19
  • MACD
  • EVGN -0.00
  • SNGX -0.07
  • Stochastic Oscillator
  • EVGN 28.13
  • SNGX 35.94

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: